What is Ocular Inflammation?
Ocular inflammation is an increase in inflammatory cells in the eye, in tissues they should not normally be in. This can affect the front of the eye, the back of the eye, or the whole eye. Ocular inflammation is also called Uveitis.
Causes of Ocular Inflammation
There are many causes and often a specific cause is not found. These include infections, systemic
inflammatory conditions, or inflammation restricted to the eye. A partial list is below:- AIDS
- Ankylosing Spondylitis
- Behcet's disease
- CMV retinitis
- Kawasaki Disease
- Multiple sclerosis
- Psoriasis
- Rheumatoid Arthritis
- Sarcoidosis
- Syphilis
- Ulcerative colitis
What is Ocular Inflammation Treatment?
Ocular Inflammation can be treated in a number of ways. This in part is determined by the cause and also may relate to the success of previous treatments.
Treatments can include:
- Steroid eye drops
- High Dose Oral Corticosteroids
- Laser Treatment
- Anti-VEGF injections into the eye
In some cases, the doctor may recommend surgical removal of eye vitreous (gel-like material) and debris from the eye to improve vision.(Vitrectomy surgery) Tests & Examination for Ocular Inflammation Treatment
These are based on your signs and symptoms and include:
- A complete eye examination,
- blood and eye fluid analysis,
- specialised photography to evaluate retinal blood flow and
- OCT scanning to determine the presence or absence of fluid within the eye.
Symptoms of Ocular Inflammation
Generally, symptoms include
- Eye redness,
- Eye Pain
- Blurry vision
- and Sensitivity to light
- Floaters, those tiny dots or specks in your vision
What are Side Effects of Ocular Inflammation Treatment?
Long-term steroid use may produce side effects such as cataracts, glaucoma, stomach ulcers, osteoporosis (bone thinning), diabetes, cardiovascular disease, weight gain, insomnia, mood changes, fluid retention, and Cushing’s syndrome.
What's The Next Step?
It is important to continue your treatment as directed as stopping prematurely may cause a relapse.